115 related articles for article (PubMed ID: 9291690)
1. The renal tubule in the progression of chronic renal failure.
Palmer BF
J Investig Med; 1997 Aug; 45(6):346-61. PubMed ID: 9291690
[No Abstract] [Full Text] [Related]
2. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
[No Abstract] [Full Text] [Related]
3. [The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis].
Ronco P
J Soc Biol; 2002; 196(4):285-91. PubMed ID: 12645297
[TBL] [Abstract][Full Text] [Related]
4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
5. [How to slow the progression of chronic renal insufficiency].
Rossert J; Ronco P
Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).
Dykeman-Sharpe J
CANNT J; 2003; 13(4):34-6; quiz 37-8. PubMed ID: 14753101
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
Renke M; Tylicki L; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
Kidney Blood Press Res; 2008; 31(6):404-10. PubMed ID: 19092257
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
Kanno Y; Okada H; Yamaji Y; Nakazato Y; Suzuki H
QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
[TBL] [Abstract][Full Text] [Related]
9. Importance of blood pressure control in chronic kidney disease.
Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
[TBL] [Abstract][Full Text] [Related]
10. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of progression of chronic renal failure and new treatment strategies].
Litwin M
Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
[TBL] [Abstract][Full Text] [Related]
12. [Renal failure in Kahler's disease].
Olmer M; Lafon J
Presse Med (1893); 1969 Jan; 77(2):41-2. PubMed ID: 5785069
[No Abstract] [Full Text] [Related]
13. Bradykinin and renal fibrosis: have we ACE'd it?
Bascands JL; Schanstra JP
J Am Soc Nephrol; 2004 Sep; 15(9):2504-6. PubMed ID: 15340002
[No Abstract] [Full Text] [Related]
14. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of progression of chronic renal damage.
Klahr S
J Nephrol; 1999; 12 Suppl 2():S53-62. PubMed ID: 10688403
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular hypertrophy induced by angiotensin II.
Wolf G; Ziyadeh FN
Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
[TBL] [Abstract][Full Text] [Related]
17. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE
Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]